header api image

Open technologies and real-time collaboration for life sciences.

Explore Open Technology for Life Sciences

OpenPharma is an industry first Open API software platform for pharma and life sciences. OpenPharma’s APIs are built for versatility. API Endpoints include: proprietary format conversion, dataset anonymization, risk scorecards and more.

APIs

Our goal with OpenPharma API is to challenge the conventional foundations of the pharmaceutical industry by providing open source tools which are key to collaboration, innovation, and connection.

Learn More
Apps

Browse and discover the cutting-edge ecosystem of OpenPharma applications. Designed specifically for the life sciences, whether large or small our applications will suit your needs.

Learn More
Docs

We’ve centralized our APIs, SDKs, Apps, and UI Library documentation to encourage development. Bring them all together and experiment in our developer sandbox for the complete OpenPharma platform experience.

Learn More

Get To Know Us

We want you to see what we're working with and what we're building.

Anonymization App Demo

Take a look at our anonymization application - a web based custom anonymization tool for all fields.

Generic Drug Supply Chain

Proof of concept used to track generic drug supply chain built upon Hedera Hashgraph.

Frontend Foundation: ReactJS

Take a peek at one of the primary tools we use to build our cutting edge applications.

React Component Library

What is a component library? A brief summary and how it is used in OpenPharma.

Hedera Micro Service

An in depth guide to using OpenPharma’s Hedera Microservice.

Modern APIs for a Progressive Life Science Landscape

At OpenPharma we believe that true innovation involves open dialog; clear communication requires mutual understanding, whether human-to-human or machine-to-machine. Our APIs are built to for flawless interoperability thus allowing the free exchange of information and ideas.

Join a community of life science interoperability.

The OpenPharma platform was engineered with you in mind. Imagine having the ability to make major leaps forward in your work and being able to share your ideas with colleagues immediately without the pain of third party applications. This is reality using OpenPharma.

APIs
Logo

Hedera Hashgraph

The Hedera hashgraph platform provides a new form of distributed consensus; a way for people who don't know or trust each other to securely collaborate and transact online without the need for a trusted intermediary.

Logo

Join a community of life science interoperability.

Hashgraph is the first asynchronouse byzantine fault tolerant (aBFT) consensus algorithm that results in fair ordering, fast finality, and secure propagation. It is the foundation of the next generation of Distributed Ledger Technology (DLT).

Hedera Hashgraph

Featured Application

Voice computing, realized. NeuroLex reduces the time to collect, model and analyze voice data from years to minutes!

Automated Interviews for Clinical Studies

NeuroLex Laboratories is one of our featured application partners, blazing a trail in artificial intelligence speech collection and analyzation. NeuroLex has created an innovative interviewing platform to screen patients into clinical trials at any phase. Instead of screening patients via telephone calls, NeuroLex created SurveyLex -- the automated voice interviewing platform.

SurveyLex
Logo
Logo

Automated Interviews for Clinical Studies

NeuroLex Laboratories is one of our featured application partners, blazing a trail in artificial intelligence speech collection and analyzation. NeuroLex has created an innovative interviewing platform to screen patients into clinical trials at any phase. Instead of screening patients via telephone calls, NeuroLex created SurveyLex -- the automated voice interviewing platform.

SurveyLex

What people say about OpenPharma:

Marsali Hancock CEO & President of EP3 Foundation
Marsali Hancock CEO & President of EP3 Foundation

Open Pharma increases patients' and providers' access to privacy protected data. Information fuels innovation. It empowers individuals with new opportunities and insights to improve health and wellness outcomes. EP3 Foundation welcomes every effort to liberate privacy protected data previously locked in silos.

Marsali Hancock CEO & President of EP3 Foundation
Dr. John Sviokla Consultant and former Harvard Business School Professor

Knowledge creation is the core of any advancement in healthcare in general and Pharma in particular.  A robust, open platform is essential in speeding up human understandings of health and disease and this is a great new step in that direction.

Marsali Hancock CEO & President of EP3 Foundation
Brad Perkins, MD Co-Founder and CEO. Sapiens Data Science, Inc.

This is a critically important effort which will accelerate science and advance health.  We look forward to participating with others on this exciting new platform and congratulate the leaders who have taken this bold step into the future.

Marsali Hancock CEO & President of EP3 Foundation
Joshua C. Rubin, JD, MBA, MPH, MPP EP3 Foundation Policy Fellow

Democratizing health together is a moral imperative of our time. Open APIs hold the potential to empower researchers, clinicians, and patients; they engender transparency and fuel collaborative innovation across pharma and life sciences to ultimately improve the health of individuals, families, communities, populations, and the general public.

Marsali Hancock CEO & President of EP3 Foundation
Jesse O’Gorman Executive Director & COO, Parallel6

Open standards and a strong community are critical to interoperability and enabling advanced clinical research. The OpenPharma platform and developer community is positioned to make a significant impact on the access, usability of and value of health data. We look forward to contributing and working with the OpenPharma community.

Marsali Hancock CEO & President of EP3 Foundation
Teri Schroeder Chief Executive Officer. ISafe Ventures.

Open technology and open API’s has a lot of value in today’s global environment. For the protection of all consumers it is imperative to deploy high assurance, standards based identity credentials when accessing sensitive data.

Marsali Hancock CEO & President of EP3 Foundation
Jonathan Hare CEO and Co-Founder WebShield Inc.

We believe open technology, open APIs are the way to go to address the decades long technology interoperability and innovation issues in life sciences. OpenPharma is a great step forward in this direction.